Effect of pirfenidone in patients with more advanced idiopathic pulmonary fibrosis

Effect of pirfenidone in patients with more advanced idiopathic pulmonary fibrosis

Abstract Data from controlled clinical studies in patients with more advanced idiopathic pulmonary fibrosis (IPF) could inform clinical practice, but they are limited, since this sub-population is usually excluded from clinical trials. These exploratory post-hoc analyses of the open-label, long-term...

Full description

Bibliographic Details
Main Authors: Ulrich Costabel, Carlo Albera, Marilyn K. Glassberg, Lisa H. Lancaster, Wim A. Wuyts, Ute Petzinger, Frank Gilberg, Klaus-Uwe Kirchgaessler, Paul W. Noble
Format: Article
Language:English
Published: BMC 2019-03-01
Series:Respiratory Research
Subjects:
Advanced disease
Antifibrotic
Idiopathic pulmonary fibrosis
Lung function
Pirfenidone
Online Access:http://link.springer.com/article/10.1186/s12931-019-1021-2

Internet

http://link.springer.com/article/10.1186/s12931-019-1021-2

Similar Items